Related Experiment Video
Updated: Jun 21, 2025

Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics
Published on: July 16, 2018
Natural Compounds as Protease Inhibitors in Therapeutic Focus on Cancer Therapy
1Department of Zoology, University of Kalyani, Kalyani, 741235, India.
Abstract:
Proteases are implicated in every hallmark of cancer and have complicated functions. For cancer cells to survive and thrive, the process of controlling intracellular proteins to keep the balance of the cell proteome is essential. Numerous natural compounds have been used as ligands/ small molecules to target various proteases that are found in the lysosomes, mitochondria, cytoplasm, and extracellular matrix, as possible anticancer therapeutics. Promising protease modulators have been developed for new drug discovery technology through recent breakthroughs in structural and chemical biology. The protein structure, function of significant tumor-related proteases, and their natural compound inhibitors have been briefly included in this study. This review highlights the most current frontiers and future perspectives for novel therapeutic approaches associated with the list of anticancer natural compounds targeting protease and the mode and mechanism of proteinase-mediated molecular pathways in cancer.
Insights
Natural compounds targeting proteases offer promising anticancer therapeutics by modulating cancer cell proteome balance. This review explores natural protease inhibitors and their mechanisms in cancer treatment.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Proteases play critical roles in all hallmarks of cancer, making them essential targets for therapeutic intervention.
- Maintaining intracellular protein homeostasis (proteome balance) is vital for cancer cell survival and proliferation.
- Natural compounds are being investigated as ligands to target proteases in various cellular compartments for anticancer drug discovery.
Purpose of the Study:
- To review the structure and function of key tumor-related proteases.
- To highlight natural compound inhibitors targeting these proteases.
- To discuss novel therapeutic strategies and future perspectives for protease-targeted cancer therapy.
Main Methods:
- Literature review of scientific databases focusing on proteases in cancer.
- Analysis of structural and chemical biology breakthroughs in protease modulator development.
- Compilation of natural compounds with anticancer properties targeting proteases.
Main Results:
- Identification of various proteases implicated in cancer progression.
- Overview of natural compounds acting as inhibitors or modulators of tumor-associated proteases.
- Discussion of the mechanisms underlying protease-mediated pathways in cancer.
Conclusions:
- Natural compounds targeting proteases represent a promising avenue for novel anticancer drug development.
- Understanding protease structure-function relationships and inhibitor mechanisms is crucial for advancing cancer therapeutics.
- Further research into natural protease modulators could lead to innovative therapeutic approaches.
More Related Videos
06:54MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Inhibition of Cdk Activity
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...